Adverse Drug Reactions
Adverse drug reactions (ADRs) are types of adverse drug events (ADEs). ADEs include ADRs, medication errors, and other drug-related problems. ADEs are the negative
Pharma Mirror Research: Pharmacists’ Satisfaction in Professional Life in Bangladesh
Author: Fahad Hussain, Founder Editor of Pharma Mirror Magazine. Background Proclamation of
Diabetes Mellitus – At a Glance with Infographics
The incidence of diabetes is growing rapidly both in the United States
NEI Corporation Introduces Prototyping Service for Electrospinning of Fibers
Somerset, New Jersey: NEI Corporation announced today a new service for producing nanoscale and microscale fibers through electrospinning. NEI is offering its knowledge
Launch of The Africa Health Forum – The First Public Private Forum on The Health Economy in Africa
Groupe Jeune Afrique and the African Development Bank announce the launch of the The Africa Health Forum, the first international
Interview: Markus Hartmann, Founder & CSO of Cilian AG, Germany
Dr Marcus Hartmann is the founder and scientific head of Cilian AG, in Münster, Germany. Established in 2001, privately held
How to Get rid of Deep Wrinkles Naturally
Wrinkles are formed when the skin loses its moisture, elasticity, and firmness. Over a period of time, they begin to
FDA Guidance for Pharma Marketers to Using Social Media
Pharma marketers have been clamoring for clear advice from the Food and Drug Administration on how to accommodate established rules
Mettler Toledo Launches New Analytical Balance Line
Greifensee, Switzerland – Metttler Toledo has released a new line of Excellence Analytical Balances focused on providing users with a high
Antisense Drugs
Definition, Designing Technology, and Mechanism Antisense drugs are drugs that seek to block DNA transcription or RNA translation in order
Disease Explained with Infographic: Dementia – The Global Pandemic
Dementia is a term which describes a number of conditions that cause damage to brain cells. Alzheimer’s disease is the
FDA approved BristolMeyers – Astrazeneca’s Farxiga to treat type 2 diabetes
The U.S. Food and Drug Administration approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in
Editorial Review – Why should Type 2 Diabetic Patients Lose their Weight?
The treatment of type 2 diabetic patients recommends losing weight since the benefits of weight loss have long been recognized